These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer. Masi I; Ottavi F; Del Rio D; Caprara V; Vastarelli C; Giannitelli SM; Fianco G; Mozetic P; Buttarelli M; Ferrandina G; Scambia G; Gallo D; Rainer A; Bagnato A; Spadaro F; Rosanò L Cell Death Dis; 2023 Jan; 14(1):73. PubMed ID: 36717550 [TBL] [Abstract][Full Text] [Related]
7. The β-arrestin1/endothelin axis bolsters ovarian fibroblast-dependent invadosome activity and cancer cell metastatic potential. Del Rio D; Masi I; Caprara V; Ottavi F; Albertini Petroni G; Salvati E; Trisciuoglio D; Giannitelli SM; Bagnato A; Mauri E; Spadaro F; Rosanò L Cell Death Dis; 2024 May; 15(5):358. PubMed ID: 38777849 [TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells. Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176 [TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 receptor drives invadopodia: Exploiting how β-arrestin-1 guides the way. Bagnato A; Rosanò L Small GTPases; 2018 Sep; 9(5):394-398. PubMed ID: 27690729 [TBL] [Abstract][Full Text] [Related]
10. Rac3 regulates breast cancer invasion and metastasis by controlling adhesion and matrix degradation. Donnelly SK; Cabrera R; Mao SPH; Christin JR; Wu B; Guo W; Bravo-Cordero JJ; Condeelis JS; Segall JE; Hodgson L J Cell Biol; 2017 Dec; 216(12):4331-4349. PubMed ID: 29061650 [TBL] [Abstract][Full Text] [Related]
11. Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase. Cianfrocca R; Rosanò L; Spinella F; Di Castro V; Natali PG; Bagnato A Can J Physiol Pharmacol; 2010 Aug; 88(8):796-801. PubMed ID: 20725137 [TBL] [Abstract][Full Text] [Related]
12. β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells. Cianfrocca R; Tocci P; Semprucci E; Spinella F; Di Castro V; Bagnato A; Rosanò L Life Sci; 2014 Nov; 118(2):179-84. PubMed ID: 24530737 [TBL] [Abstract][Full Text] [Related]
13. Functional interaction between endothelin-1 and ZEB1/YAP signaling regulates cellular plasticity and metastasis in high-grade serous ovarian cancer. Sestito R; Tocci P; Roman C; Di Castro V; Bagnato A J Exp Clin Cancer Res; 2022 Apr; 41(1):157. PubMed ID: 35477522 [TBL] [Abstract][Full Text] [Related]
14. β-arrestin1 at the cross-road of endothelin-1 signaling in cancer. Rosanò L; Bagnato A J Exp Clin Cancer Res; 2016 Jul; 35(1):121. PubMed ID: 27473335 [TBL] [Abstract][Full Text] [Related]
15. Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy. Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Caprara V; Semprucci E; Ferrandina G; Natali PG; Bagnato A Cancer Res; 2014 Dec; 74(24):7453-64. PubMed ID: 25377471 [TBL] [Abstract][Full Text] [Related]
16. Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis. Teoh JP; Park KM; Wang Y; Hu Q; Kim S; Wu G; Huang S; Maihle N; Kim IM Cell Signal; 2014 Dec; 26(12):2885-95. PubMed ID: 25194819 [TBL] [Abstract][Full Text] [Related]
17. Phosphorylated cortactin recruits Vav2 guanine nucleotide exchange factor to activate Rac3 and promote invadopodial function in invasive breast cancer cells. Rosenberg BJ; Gil-Henn H; Mader CC; Halo T; Yin T; Condeelis J; Machida K; Wu YI; Koleske AJ Mol Biol Cell; 2017 May; 28(10):1347-1360. PubMed ID: 28356423 [TBL] [Abstract][Full Text] [Related]
18. Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma. Rosanò L; Spinella F; Di Castro V; Dedhar S; Nicotra MR; Natali PG; Bagnato A Mol Cancer Ther; 2006 Apr; 5(4):833-42. PubMed ID: 16648553 [TBL] [Abstract][Full Text] [Related]
19. Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer. Rosanò L; Cianfrocca R; Sestito R; Tocci P; Di Castro V; Bagnato A Expert Opin Ther Targets; 2017 Oct; 21(10):925-932. PubMed ID: 28758529 [TBL] [Abstract][Full Text] [Related]
20. Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer. Cianfrocca R; Rosanò L; Tocci P; Sestito R; Caprara V; Di Castro V; De Maria R; Bagnato A Cell Death Differ; 2017 Oct; 24(10):1811-1820. PubMed ID: 28708138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]